170 related articles for article (PubMed ID: 29364480)
21. Expression of CXCR4 and VEGF-C is correlated with lymph node metastasis in non-small cell lung cancer.
Bi MM; Shang B; Wang Z; Chen G
Thorac Cancer; 2017 Nov; 8(6):634-641. PubMed ID: 28925100
[TBL] [Abstract][Full Text] [Related]
22. [Upregulation of survivin in non-small cell lung cancer and its clinicopathological correlation with p53 and Bcl-2].
Han PH; Li XJ; Qin H; Yao J; DU N; Ren H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Aug; 25(8):710-3. PubMed ID: 19664395
[TBL] [Abstract][Full Text] [Related]
23. Association of p53/p21 expression and cigarette smoking with tumor progression and poor prognosis in non-small cell lung cancer patients.
Xie D; Lan L; Huang K; Chen L; Xu C; Wang R; Shi Y; Wu X; Wang L; Liu Y; Lu B
Oncol Rep; 2014 Dec; 32(6):2517-26. PubMed ID: 25333671
[TBL] [Abstract][Full Text] [Related]
24. [Correlations of S100A4 and MMP9 expressions to infiltration, metastasis and prognosis of non-small cell lung cancer].
Chen XL; Wang LC; Zhang WG; Chen XY; Sun ZM
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1254-8. PubMed ID: 18676277
[TBL] [Abstract][Full Text] [Related]
25. Relationship between Contrast-Enhanced CT and Clinicopathological Characteristics and Prognosis of Non-Small Cell Lung Cancer.
Yang H; Fan HX; Song LH; Xie JC; Fan SF
Oncol Res Treat; 2017; 40(9):516-522. PubMed ID: 28866685
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-122-5p promotes the development of non-small cell lung cancer via downregulating p53 and activating PI3K-AKT pathway.
Fan X; Wu X
J BUON; 2019; 24(1):273-279. PubMed ID: 30941980
[TBL] [Abstract][Full Text] [Related]
27. Histone deacetylase inhibitors sensitize human non-small cell lung cancer cells to ionizing radiation through acetyl p53-mediated c-myc down-regulation.
Seo SK; Jin HO; Woo SH; Kim YS; An S; Lee JH; Hong SI; Lee KH; Choe TB; Park IC
J Thorac Oncol; 2011 Aug; 6(8):1313-9. PubMed ID: 21642861
[TBL] [Abstract][Full Text] [Related]
28. [Clinicopathological study on nodal molecular staging of non-small-cell lung cancer].
Wang YX; Sun YE; Li XH; Wang ZB; Liu YL; Chen LA; Zhang GK
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):161-4. PubMed ID: 17425845
[TBL] [Abstract][Full Text] [Related]
29. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer.
Takizawa H; Kondo K; Fujino H; Kenzaki K; Miyoshi T; Sakiyama S; Tangoku A
Br J Cancer; 2006 Jul; 95(1):75-9. PubMed ID: 16755294
[TBL] [Abstract][Full Text] [Related]
30. [Comparative study for detecting micrometastases of lymph nodes in patients with lung cancer].
Wang YX; Sun YE; Li XH; Wang ZB; Liu YL; Chen LA; Tong XY
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):19-21. PubMed ID: 18346373
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of circulating c-met messenger RNA is significantly correlated with nodal stage and early recurrence in non-small cell lung cancer.
Cheng TL; Chang MY; Huang SY; Sheu CC; Kao EL; Cheng YJ; Chong IW
Chest; 2005 Sep; 128(3):1453-60. PubMed ID: 16162743
[TBL] [Abstract][Full Text] [Related]
32. [Effects of 5-Aza-2-deoxycytidine on DNA methylation of anti-oncogenes in non-small cell lung cancer cells].
Fang HL; Yu ZC; Zhu HB; Jin YT
Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):658-63. PubMed ID: 23159077
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
34. [Expression of special AT-rich sequence-binding protein mRNA and its clinicopathological significance in non-small cell lung cancer].
Zhou LY; Liu F; Tong J; Chen QQ; Zhang FW
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):534-7. PubMed ID: 19304547
[TBL] [Abstract][Full Text] [Related]
35. [Expression and significance of telomerase reverse transcriptase and its regulators in non-small cell lung carcinoma].
Chen TX; Xiong YY; Liu L
Ai Zheng; 2004 Mar; 23(3):273-7. PubMed ID: 15025956
[TBL] [Abstract][Full Text] [Related]
36. [Abnormal expression of Thy-1 as a novel tumor marker in lung cancer and its prognostic significance].
Chen JF; Zhang LJ; Zhao AL; Wang Y; Wu N; Xiong HC; Liang Z; Li JY; Huang XF; Yang Y
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1921-5. PubMed ID: 16255990
[TBL] [Abstract][Full Text] [Related]
37. PBK/TOPK expression in non-small-cell lung cancer: its correlation and prognostic significance with Ki67 and p53 expression.
Lei B; Liu S; Qi W; Zhao Y; Li Y; Lin N; Xu X; Zhi C; Mei J; Yan Z; Wan L; Shen H
Histopathology; 2013 Nov; 63(5):696-703. PubMed ID: 24025073
[TBL] [Abstract][Full Text] [Related]
38. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer.
Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G
Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877
[TBL] [Abstract][Full Text] [Related]
39. [Expression of AKT2, cyclin D1, and MMP-9 and their correlations to clinicopathologic features of non-small cell lung cancer].
Wang J; Miao LJ; Wu YM; Wu YJ; Wang XC
Ai Zheng; 2006 Jan; 25(1):69-72. PubMed ID: 16405753
[TBL] [Abstract][Full Text] [Related]
40. p53, BCL-2 and BAX in non-small cell lung cancer brain metastases: a comparison of real-time RT-PCR, ELISA and immunohistochemical techniques.
Stark AM; Hugo HH; Tscheslog H; Mehdorn HM
Neurol Res; 2007 Jul; 29(5):435-40. PubMed ID: 17535549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]